Cellebrite DI's stock dropped 19% after releasing full-year results in line with analyst forecasts. Analysts expect a 21% revenue increase and a profit of $0.27 per share in 2025.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay
Cellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price Targets
